[Nephropathy caused by radiocontrast media]
- PMID: 16334535
[Nephropathy caused by radiocontrast media]
Abstract
The paper contains the overview of the definition, clinical features, pathomechanism and the risk factors of the radiocontrast-induced nephropathy. Authors reviewed the methods of prevention and treatment of the renal failure induced by radiocontrast media with the special attendance to the results of the latest clinical trials.
Similar articles
-
Dopamine-1 receptor agonist: renal effects and its potential role in the management of radiocontrast-induced nephropathy.J Clin Pharmacol. 2004 Dec;44(12):1342-51. doi: 10.1177/0091270004269842. J Clin Pharmacol. 2004. PMID: 15545304 Review.
-
Radiocontrast-induced acute renal failure: allocations and outcomes.Rev Cardiovasc Med. 2001;2 Suppl 1:S9-13. Rev Cardiovasc Med. 2001. PMID: 12439362 Review.
-
Design and rationale of CONTRAST--a prospective, randomized, placebo-controlled trial of fenoldopam mesylate for the prevention of radiocontrast nephropathy.Rev Cardiovasc Med. 2001;2 Suppl 1:S31-6. Rev Cardiovasc Med. 2001. PMID: 12439366 Clinical Trial.
-
Radiocontrast nephropathy: the dye is not cast.Rev Cardiovasc Med. 2000 Summer;1(1):43-54. Rev Cardiovasc Med. 2000. PMID: 12457151 Review.
-
[Pathophysiology and prevention of contrast-induced acute renal failure].G Ital Nefrol. 2007 Sep-Oct;24 Suppl 38:20-4. G Ital Nefrol. 2007. PMID: 17922443 Italian.